Intimation of Newspaper Advertisement of Novartis India Limited ("The Company/ The Target Company") regarding the reasoned recommendations of the Committee of Independent Directors ("IDC").
Intimation of Recommendations by the Committee of Independent Directors ("IDC") pursuant to Regulation 26(7) of the SEBI (SAST) Regulations, 2011.
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 relating to the Receipt of the Letter of Offer from Axis Capital Limited (Manager to the Open Offer).
Intimation of sending Reminder to respective shareholders for transfer of Shares of Novartis India Limited ("The Company") to Investor Education & Protection Fund ("IEPF").
Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
Declaration of Voting Results of the Postal Ballot of Novartis India Limited ("The Company") and Scrutinizer's Report.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 90.60 | 78.76 | 84.54 | 81.17 | 92.29 | 87.10 | 93.00 | 83.88 | 87.55 | 90.33 | 85.90 | 90.55 |
| YOY Revenue Growth % | -25.07% | -22.42% | 5.45% | 6.62% | 1.87% | 10.59% | 10.01% | 3.34% | -5.14% | 3.71% | -7.63% | 7.95% |
| Other Income | 12.47 | 16.88 | 21.96 | 10.42 | 10.41 | 10.32 | 10.60 | 10.63 | 10.61 | 9.40 | 8.75 | 10.01 |
| Total Income | 103.07 | 95.64 | 106.50 | 91.59 | 102.70 | 97.42 | 103.60 | 94.51 | 98.16 | 99.73 | 94.65 | 100.56 |
| Total Expenses + | 75.30 | 63.21 | 65.19 | 70.26 | 69.02 | 69.86 | 68.31 | 60.62 | 60.94 | 67.08 | 65.00 | 70.42 |
| Cost of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employee Benefit Expense | 6.18 | 5.37 | 6.30 | 5.11 | 5.54 | 5.20 | 4.81 | 3.17 | 5.29 | 5.30 | 6.14 | 4.35 |
| Other Expenses | 14.36 | 11.76 | 12.98 | 7.96 | 8.87 | 14.79 | 12.15 | 7.50 | 8.25 | 10.63 | 8.50 | 13.40 |
| Operating Profit | 15.30 | 15.55 | 19.35 | 10.91 | 23.27 | 17.24 | 24.69 | 23.26 | 26.61 | 23.25 | 20.90 | 20.13 |
| OPM % | 16.9% | 19.7% | 22.9% | 13.4% | 25.2% | 19.8% | 26.5% | 27.7% | 30.4% | 25.7% | 24.3% | 22.2% |
| Profit Before Tax + | 27.77 | 32.43 | 41.31 | 21.33 | 33.68 | 27.56 | 35.29 | 33.89 | 37.22 | 32.65 | 29.65 | 30.14 |
| Tax Expense | 7.51 | 8.75 | 14.74 | 6.65 | 7.94 | 7.15 | 9.84 | 4.59 | 9.60 | 8.43 | 13.56 | 4.89 |
| Tax % | 27% | 27% | 35.7% | 31.2% | 23.6% | 25.9% | 27.9% | 13.5% | 25.8% | 25.8% | 45.7% | 16.2% |
| Profit After Tax | 20.26 | 23.68 | 26.57 | 14.68 | 25.74 | 20.41 | 25.45 | 29.30 | 27.62 | 24.22 | 16.09 | 25.25 |
| EPS (Basic) | 8.21 | 9.59 | 10.76 | 5.95 | 10.42 | 8.27 | 10.31 | 11.87 | 11.19 | 9.81 | 6.52 | 10.23 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 354.33 | 356.27 | 335.07 | 378.74 | 399.87 | 381.35 |
| YOY Revenue Growth % | -0.54% | 6.33% | -11.53% | -5.28% | 4.86% | - |
| Other Income | 38.77 | 41.96 | 61.68 | 58.11 | 33.19 | 33.09 |
| Total Income | 393.10 | 398.23 | 396.75 | 436.85 | 433.06 | 414.44 |
| Total Expenses + | 263.44 | 267.81 | 273.91 | 321.47 | 387.24 | 374.40 |
| Employee Benefit Expense | 21.08 | 18.72 | 22.96 | 35.64 | 101.89 | 108.51 |
| Other Expenses | 40.78 | 43.31 | 47.01 | 76.33 | 92.74 | 99.43 |
| Operating Profit | 90.89 | 88.46 | 61.16 | 57.27 | 12.63 | 6.95 |
| OPM % | 25.7% | 24.8% | 18.3% | 15.1% | 3.2% | 1.8% |
| Profit Before Exceptional | 129.66 | 130.42 | 122.84 | 115.38 | 45.82 | 40.04 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -49.64 | 0.00 |
| Profit Before Tax + | 129.66 | 130.42 | 122.84 | 115.38 | -3.82 | 40.04 |
| Tax Expense | 36.48 | 29.52 | 37.65 | 12.02 | -0.10 | 19.14 |
| Tax % | 28.1% | 22.6% | 30.6% | 10.4% | - | 47.8% |
| Profit After Tax | 93.18 | 100.90 | 85.19 | 103.36 | -3.72 | 20.90 |
| EPS (Basic) | 37.74 | 40.87 | 34.50 | 41.86 | -1.51 | 8.46 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 210.02 | 201.99 | 225.67 | 305.61 | 248.84 | 278.25 |
| Property, Plant & Equipment | 2.88 | 4.54 | 6.94 | 19.25 | 23.65 | 63.91 |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets + | 768.25 | 745.82 | 699.26 | 677.29 | 707.82 | 723.13 |
| Inventories | 53.32 | 41.11 | 44.86 | 54.72 | 57.07 | 47.95 |
| Trade Receivables | 37.05 | 40.14 | 41.47 | 36.16 | 44.56 | 38.73 |
| Cash and Cash Equivalents | 52.50 | 52.07 | 44.98 | 19.42 | 158.35 | 68.27 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 817.83 | 784.96 | 744.82 | 775.66 | 691.70 | 711.19 |
| Equity Share Capital | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 |
| Other Equity | 805.49 | 772.62 | 732.48 | 763.32 | 679.36 | 698.85 |
| Non-Current Liabilities | 15.47 | 20.80 | 22.91 | 47.79 | 49.45 | 132.15 |
| Current Liabilities | 144.97 | 142.05 | 157.20 | 159.49 | 216.42 | 158.95 |
| Total Liabilities | 160.44 | 162.85 | 180.11 | 207.28 | 265.87 | 291.10 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 46.73 | 74.57 | 113.40 | 44.80 | 38.67 | -69.21 |
| Cash from Investing Activities | 17.63 | -3.31 | 33.13 | -153.25 | 87.04 | 95.16 |
| Cash from Financing Activities | -63.93 | -64.15 | -120.99 | -30.48 | -35.63 | -36.80 |
| Net Increase/Decrease in Cash | 0.43 | 7.11 | 25.54 | -138.93 | 90.08 | -10.85 |